Efficacy of GLP-1 receptor agonists for steroid-induced hyperglycemia in patients with diabetes
Not Applicable
- Conditions
- Diabetes
- Registration Number
- JPRN-UMIN000034083
- Lead Sponsor
- Center for diabetes and endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects who refuse to participate in the study 2)Subjects who type 1 diabetes 3)Subjects with insulin-dependent diabetes 4)Subjects who used GLP-1 receptor agonists within one month 5)Subjects who are critically ill 6)Subjects who have difficulty participating in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycemic control and total daily insulin dose
- Secondary Outcome Measures
Name Time Method Glycemic variation, adverse events including hypoglycemia, body weight, blood pressure, and lipid profile